Concepedia

Dazheng Ling

DL

8

Publications

275

Citations

8

H-Index

2016

Active since

Affiliations

East China University of Science and Technology(Current)

University of Chinese Academy of Sciences

ShanghaiTech University

Institut Pasteur of Shanghai

Shanghai University

Dazheng Ling is an author at East China University of Science and Technology specializing in drug discovery, drug development, and medicine.

Top concepts

Publications per year

2016–2022

8

Publications

8

Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer’s Disease

Fei Mao, Huan Wang, Wei Ni et al. · ACS Chemical Neuroscience · 2017 · 61 citations

, , +25

A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1

Zhenghui Huang, Ruoxi Li, Tongke Tang et al. · Cell Discovery · 2020 · 53 citations · Full text

Discovery of Novel <i>Plasmodium falciparum</i> HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat

Ruoxi Li, Dazheng Ling, Tongke Tang et al. · Journal of Medicinal Chemistry · 2021 · 41 citations · Full text

Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery

Fei Mao, Qingya Kong, Wei Ni et al. · ChemistryOpen · 2016 · 34 citations · Full text

, , +18

Drug Repurposing of Quisinostat to Discover Novel <i>Plasmodium falciparum</i> HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety

Manjiong Wang, Tongke Tang, Ruoxi Li et al. · Journal of Medicinal Chemistry · 2022 · 32 citations · Full text

Rows per page

1–5 of 8